Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3082832019 | Daclatasvir (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 3082833012 | Daclatasvir | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Daclatasvir (substance) | Is a | Anti-infective agent (substance) | true | Inferred relationship | Some | ||
| Daclatasvir (substance) | Is a | Substance categorized by disposition | true | Inferred relationship | Some | ||
| Daclatasvir (substance) | Has disposition (attribute) | Disposition | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 60 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Daclatasvir (substance) | Inferred relationship | Some | 1 |
| Product containing only daclatasvir (medicinal product) | Has active ingredient | True | Daclatasvir (substance) | Inferred relationship | Some | 1 |
| Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Daclatasvir (substance) | Inferred relationship | Some | 1 |
Reference Sets
FHIR